225 related articles for article (PubMed ID: 15475413)
1. Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta.
Kobayashi D; Ieiri I; Hirota T; Takane H; Maegawa S; Kigawa J; Suzuki H; Nanba E; Oshimura M; Terakawa N; Otsubo K; Mine K; Sugiyama Y
Drug Metab Dispos; 2005 Jan; 33(1):94-101. PubMed ID: 15475413
[TBL] [Abstract][Full Text] [Related]
2. C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance.
Imai Y; Nakane M; Kage K; Tsukahara S; Ishikawa E; Tsuruo T; Miki Y; Sugimoto Y
Mol Cancer Ther; 2002 Jun; 1(8):611-6. PubMed ID: 12479221
[TBL] [Abstract][Full Text] [Related]
3. Interindividual Regulation of the Breast Cancer Resistance Protein/
Bircsak KM; Moscovitz JE; Wen X; Archer F; Yuen PYS; Mohammed M; Memon N; Weinberger BI; Saba LM; Vetrano AM; Aleksunes LM
Drug Metab Dispos; 2018 May; 46(5):619-627. PubMed ID: 29386232
[TBL] [Abstract][Full Text] [Related]
4. Functional SNPs of the breast cancer resistance protein-therapeutic effects and inhibitor development.
Yanase K; Tsukahara S; Mitsuhashi J; Sugimoto Y
Cancer Lett; 2006 Mar; 234(1):73-80. PubMed ID: 16303243
[TBL] [Abstract][Full Text] [Related]
5. Genetic and Dietary Regulation of Glyburide Efflux by the Human Placental Breast Cancer Resistance Protein Transporter.
Bircsak KM; Gupta V; Yuen PY; Gorczyca L; Weinberger BI; Vetrano AM; Aleksunes LM
J Pharmacol Exp Ther; 2016 Apr; 357(1):103-13. PubMed ID: 26850786
[TBL] [Abstract][Full Text] [Related]
6. Ethnic differences in ATP-binding cassette transporter, sub-family G, member 2 (ABCG2/BCRP): genotype combinations and estimated functions.
Sakiyama M; Matsuo H; Takada Y; Nakamura T; Nakayama A; Takada T; Kitajiri S; Wakai K; Suzuki H; Shinomiya N
Drug Metab Pharmacokinet; 2014; 29(6):490-2. PubMed ID: 24869748
[TBL] [Abstract][Full Text] [Related]
7. Association of breast cancer resistance protein/ABCG2 phenotypes and novel promoter and intron 1 single nucleotide polymorphisms.
Poonkuzhali B; Lamba J; Strom S; Sparreboom A; Thummel K; Watkins P; Schuetz E
Drug Metab Dispos; 2008 Apr; 36(4):780-95. PubMed ID: 18180275
[TBL] [Abstract][Full Text] [Related]
8. Natural allelic variants of breast cancer resistance protein (BCRP) and their relationship to BCRP expression in human intestine.
Zamber CP; Lamba JK; Yasuda K; Farnum J; Thummel K; Schuetz JD; Schuetz EG
Pharmacogenetics; 2003 Jan; 13(1):19-28. PubMed ID: 12544509
[TBL] [Abstract][Full Text] [Related]
9. Associations between ABCG2 gene polymorphisms and isolated septal defects in a Han Chinese population.
Wang C; Xie L; Li H; Li Y; Mu D; Zhou R; Liu R; Zhou K; Hua Y
DNA Cell Biol; 2014 Oct; 33(10):689-98. PubMed ID: 24979295
[TBL] [Abstract][Full Text] [Related]
10. Identification and functional assessment of BCRP polymorphisms in a Korean population.
Lee SS; Jeong HE; Yi JM; Jung HJ; Jang JE; Kim EY; Lee SJ; Shin JG
Drug Metab Dispos; 2007 Apr; 35(4):623-32. PubMed ID: 17237154
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer resistance protein (BCRP)-mediated glyburide transport: effect of the C421A/Q141K BCRP single-nucleotide polymorphism.
Pollex EK; Anger G; Hutson J; Koren G; Piquette-Miller M
Drug Metab Dispos; 2010 May; 38(5):740-4. PubMed ID: 20159988
[TBL] [Abstract][Full Text] [Related]
12. ABCG2 polymorphisms, 34G>A and 421C>A in a Korean population: analysis and a comprehensive comparison with other populations.
Kim KA; Joo HJ; Park JY
J Clin Pharm Ther; 2010 Dec; 35(6):705-12. PubMed ID: 21054463
[TBL] [Abstract][Full Text] [Related]
13. The C421A (Q141K) polymorphism enhances the 3'-untranslated region (3'-UTR)-dependent regulation of ATP-binding cassette transporter ABCG2.
Ripperger A; Benndorf RA
Biochem Pharmacol; 2016 Mar; 104():139-47. PubMed ID: 26903388
[TBL] [Abstract][Full Text] [Related]
14. Effect of oxygen on multidrug resistance in the first trimester human placenta.
Lye P; Bloise E; Dunk C; Javam M; Gibb W; Lye SJ; Matthews SG
Placenta; 2013 Sep; 34(9):817-23. PubMed ID: 23790363
[TBL] [Abstract][Full Text] [Related]
15. Protective role of the placental efflux transporter BCRP/ABCG2 in the relationship between prenatal cadmium exposure, placenta weight, and size at birth.
Barrett ES; Rivera-Núñez Z; Getz K; Ohman-Strickland P; Zhang R; Kozlosky D; Doherty CL; Buckley BT; Brunner J; Miller RK; O'Connor TG; Aleksunes LM
Environ Res; 2023 May; 225():115597. PubMed ID: 36863650
[TBL] [Abstract][Full Text] [Related]
16. BCRP/ABCG2 in the placenta: expression, function and regulation.
Mao Q
Pharm Res; 2008 Jun; 25(6):1244-55. PubMed ID: 18202831
[TBL] [Abstract][Full Text] [Related]
17. The ABCG2 C421A polymorphism does not affect oral nitrofurantoin pharmacokinetics in healthy Chinese male subjects.
Adkison KK; Vaidya SS; Lee DY; Koo SH; Li L; Mehta AA; Gross AS; Polli JW; Lou Y; Lee EJ
Br J Clin Pharmacol; 2008 Aug; 66(2):233-9. PubMed ID: 18429968
[TBL] [Abstract][Full Text] [Related]
18. Expression and functional activity of breast cancer resistance protein (BCRP, ABCG2) transporter in the human choriocarcinoma cell line BeWo.
Ceckova M; Libra A; Pavek P; Nachtigal P; Brabec M; Fuchs R; Staud F
Clin Exp Pharmacol Physiol; 2006; 33(1-2):58-65. PubMed ID: 16445700
[TBL] [Abstract][Full Text] [Related]
19. Regional expression of the BCRP/ABCG2 transporter in term human placentas.
Memon N; Bircsak KM; Archer F; Gibson CJ; Ohman-Strickland P; Weinberger BI; Parast MM; Vetrano AM; Aleksunes LM
Reprod Toxicol; 2014 Jan; 43():72-77. PubMed ID: 24269555
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer resistance protein: molecular target for anticancer drug resistance and pharmacokinetics/pharmacodynamics.
Sugimoto Y; Tsukahara S; Ishikawa E; Mitsuhashi J
Cancer Sci; 2005 Aug; 96(8):457-65. PubMed ID: 16108826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]